Proportion of isolates with resistance to ciprofloxacin reported to in Norway
Norway: Proportion of isolates with resistance to ciprofloxacin reported to was 55.6 in 2018. ▼ Falling
Proportion of isolates with resistance to ciprofloxacin reported to in Norway, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for proportion of isolates with resistance to ciprofloxacin reported to in Norway is 55.6, measured in 2018.
That represents a change of up 26.7% on the previous year and down 30.5% over ten years.
Over the whole period, proportion of isolates with resistance to ciprofloxacin reported to in Norway peaked at 80 in 2009 and was at its lowest, 32.47, in 2011.
That places Norway 33rd out of 54 countries with data for 2018, putting it in the middle of the range.
Proportion of isolates with resistance to ciprofloxacin reported to in Norway, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 80 | — |
| 2010 | 34.78 | -56.5% |
| 2011 | 32.47 | -6.7% |
| 2012 | 55.45 | +70.8% |
| 2013 | 79.46 | +43.3% |
| 2014 | 73.64 | -7.3% |
| 2015 | 58.72 | -20.3% |
| 2016 | 45.95 | -21.7% |
| 2017 | 43.9 | -4.5% |
| 2018 | 55.6 | +26.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 80 | 80 | 80 | 1 |
| 2010s | 53.33 | 32.47 | 79.46 | 9 |
Countries ranked near Norway
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,212 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.217 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0238 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0617 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with resistance to ciprofloxacin reported to in Norway?
- Proportion of isolates with resistance to ciprofloxacin reported to in Norway was 55.6 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to ciprofloxacin reported to recorded in Norway?
- The highest recorded value was 80 in 2009.
- What is the lowest proportion of isolates with resistance to ciprofloxacin reported to recorded in Norway?
- The lowest recorded value was 32.47 in 2011.
- How does Norway rank for proportion of isolates with resistance to ciprofloxacin reported to?
- Norway ranks 33rd out of 54 countries with data for 2018.
- Is proportion of isolates with resistance to ciprofloxacin reported to rising or falling in Norway?
- Over the last ten years it is down 30.5%. The long-run trend across the full record is falling.
- Where does this Norway data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).